Literature DB >> 1864584

Familial amyloidotic polyneuropathy type 1 in Kumamoto, Japan: a clinicopathologic, histochemical, immunohistochemical, and ultrastructural study.

K Takahashi1, S Yi, Y Kimura, S Araki.   

Abstract

Seventeen autopsy and five biopsy cases of familial amyloidotic polyneuropathy were examined clinicopathologically, histochemically, immunohistochemically, and ultrastructurally. In the autopsy cases, amyloid deposits were predominant in the peripheral nerve tissues, autonomic nervous system, choroid plexus, cardiovascular system, and kidneys. Amyloid involvements in the anterior and posterior roots of the spinal cord, spinal ganglia, thyroid, and gastrointestinal tract were also frequent. In the cardiac conduction system, amyloid deposition was prominent in the sinoatrial node and in limbs of the intraventricular bundle. In the sural nerve biopsy, besides amyloid deposits, degenerative changes of nerve fibers and Schwann cells were detected ultrastructurally, and the morphometric analysis showed a marked reduction in the number of myelinated fibers which correlated with the clinical stage. Amyloid deposits were resistant to pretreatment with potassium permanganate in Congo red staining, and transthyretin was confirmed immunohistochemically as a major component of amyloid deposits, along with the presence of serum amyloid P-component. Besides the amyloid deposits, transthyretin was proven in the liver cells, epithelial cells of the choroid plexus, and pancreatic islet A cells, suggesting that the transthyretin produced by these cells is secreted, transferred into tissues, and deposited in situ as the major component of amyloid in this disorder.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1864584     DOI: 10.1016/0046-8177(91)90227-g

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  18 in total

1.  Electrophysiological features of late-onset transthyretin Met30 familial amyloid polyneuropathy unrelated to endemic foci.

Authors:  Haruki Koike; Yuichi Kawagashira; Masahiro Iijima; Masahiko Yamamoto; Naoki Hattori; Fumiaki Tanaka; Masaaki Hirayama; Yukio Ando; Shu-ichi Ikeda; Gen Sobue
Journal:  J Neurol       Date:  2008-09-24       Impact factor: 4.849

Review 2.  Leptomeningeal amyloid and variant transthyretins.

Authors:  M D Benson
Journal:  Am J Pathol       Date:  1996-02       Impact factor: 4.307

3.  Comparison of amyloid deposition in two lines of transgenic mouse that model familial amyloidotic polyneuropathy, type I.

Authors:  Y Takaoka; F Tashiro; S Yi; S Maeda; K Shimada; K Takahashi; Y Sakaki; K Yamamura
Journal:  Transgenic Res       Date:  1997-07       Impact factor: 2.788

4.  Familial amyloid polyneuropathy: hypertrophy of ligaments supporting the spinal cord.

Authors:  Mika Kitajima; Yukunori Korogi; Masayuki Yamura; Ichiro Ikushima; Yoshiko Hayashida; Yukio Ando; Makoto Uchino; Yasuyuki Yamashita
Journal:  AJNR Am J Neuroradiol       Date:  2004-10       Impact factor: 3.825

5.  Pathological changes long after liver transplantation in a familial amyloidotic polyneuropathy patient.

Authors:  Konen Obayashi; Mitsuharu Ueda; Toshinori Oshima; Satomi Kawahara; Yohei Misumi; Taro Yamashita; Hirofumi Jono; Masahide Yazaki; Fuyuki Kametani; Shu-ichi Ikeda; Yuki Ohya; Katsuhiro Asonuma; Yukihiro Inomata; Yukio Ando
Journal:  BMJ Case Rep       Date:  2012-08-18

6.  Tissue distribution, biochemical properties, and transmission of mouse type A AApoAII amyloid fibrils.

Authors:  Tatsumi Korenaga; Xiaoying Fu; Yanming Xing; Takatoshi Matsusita; Kazunao Kuramoto; Seigo Syumiya; Kazuhiro Hasegawa; Hironobu Naiki; Masaki Ueno; Tokuhiro Ishihara; Masanori Hosokawa; Masayuki Mori; Keiichi Higuchi
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

Review 7.  Systemic amyloidosis in transgenic mice carrying the human mutant transthyretin (Met 30) gene. Pathological and immunohistochemical similarity to human familial amyloidotic polyneuropathy, type I.

Authors:  S Araki; S Yi; T Murakami; S Watanabe; S Ikegawa; K Takahashi; K Yamarnura
Journal:  Mol Neurobiol       Date:  1994-02       Impact factor: 5.590

8.  Quantitative sensation and autonomic test abnormalities in transthyretin amyloidosis polyneuropathy.

Authors:  Dong Hwee Kim; Steven R Zeldenrust; Phillip A Low; Peter J Dyck
Journal:  Muscle Nerve       Date:  2009-09       Impact factor: 3.217

9.  Type I familial amyloid polyneuropathy and pontine haemorrhage.

Authors:  J Arpa Gutiérrez; C Morales; M Lara; C Muñoz; M García-Rojo; A Caminero; M Gutiérrez
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

10.  Transthyretin amyloid goiter in a renal allograft recipient.

Authors:  Vijay K Vanguri; Vânia Nosé
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.